IP Library Granted Patent US 9,877,892
Granted Patent B2
US 9,877,892 · App. 14/738,518 · Granted Jan 30, 2018

System and method for titrating in vivo cellular reaction and gene expression using varying oscillation frequencies

Inventors: Robert Edward Grant (Laguna Beach, CA); Todd Mirzai (Honolulu, HI); Matthew T. Case (Laguna Hills, CA)
Assignee: Strathspey Crown Holdings, LLC
A61H23/0236A61H2201/1623A61H2201/5097A61H2203/0456A61H2205/081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,877,892
App. No.
14/738,518
Granted
Jan 30, 2018
Kind
B2
Abstract

A system and method for directing vibrational oscillating sonic waves toward a target tissue in the body of a person, to thereby influence a phenotypic differentiation of the target tissue at a cellular level, requires the use of an epidermal or implantable patch. Mounted on the patch is a sonic generator for generating sonic energy that entrains cellular functions of the target tissue for a desired phenotypic response. Also included is a unit for titrating the target tissue to monitor for changes in an expression level of the target tissue resulting from phenotypic differentiation.

Claims (35)

1. A system is provided for directing vibrational oscillating sonic waves toward a target tissue in the body of a person to influence a phenotypic differentiation of the target tissue at a cellular level, the system comprising:

a patch having a base member;

a means for holding the base member in a preselected location on the person;

a sonic generator mounted on the base member for generating a sonic wave in accordance with a scheduled program, wherein the sonic wave includes at least one predetermined frequency from the program to entrain cellular functions of the target tissue for a desired phenotypic response; and

a unit for titrating the target tissue to monitor for changes in an expression level of the target tissue resulting from phenotypic differentiation, and to indicate a termination of epidermal patch operation when the desired phenotypic response has been achieved.

2. The system as recited in claim 1 further comprising a sounding board mounted on the base member to direct vibrational oscillation frequencies of the sound wave toward the target tissue, wherein the means for holding the base member on the person is a connector selected from a group consisting of a fastener and an adhesive.

3. The system as recited in claim 1 further comprising:

a transceiver mounted on the base member and connected with the sonic generator; and

a central control unit for receiving signals from the transceiver, wherein the signals include information pertinent to the operation of the sonic generator.

4. The system as recited in claim 3 wherein the titration unit is connected to the central control unit to provide the central control unit with epigenetic information regarding the expression level of the target tissue pertinent to the phenotypic differentiation of the target tissue.

5. The system as recited in claim 4 wherein the central control unit varies the frequency of the sonic wave in accordance with the scheduled program, and compares information from the titration unit with the desired phenotypic response to determine when the desired phenotypic response has been achieved.

6. The system as recited in claim 4 wherein the titration unit is selected from a group consisting of an Optical Coherence Tomography (OCT) device, and an Ultrasound device.

7. The system as recited in claim 4 wherein the titration unit requires a biopsy of the target tissue.

8. The system as recited in claim 1 wherein the predetermined sonic frequency is selected from a sonic spectrum including infrasonic, audible sonic, and ultrasonic frequencies, and further wherein the phenotypic response is selected from the group consisting of improved health and wellness, and meditative and brain wave/relaxation states.

9. The system as recited in claim 1 wherein the sonic wave has a frequency resonant with the natural frequency of the target tissue.

10. The system as recited in claim 1 wherein the patch in implantable.

11. A method for directing vibrational oscillating sonic waves toward a target tissue in the body of a person to influence a phenotypic differentiation of the target tissue at a cellular level, the method comprising the steps of:

positioning a patch having a base member at a preselected location on the person, wherein the patch includes a sonic generator;

operating the sonic generator to generate a sonic wave in accordance with a scheduled program, wherein the sonic wave includes at least one predetermined frequency from the program to entrain cellular functions of the target tissue for a desired phenotypic response; and

titrating the target tissue to monitor for changes in an expression level of the target tissue resulting from phenotypic differentiation, and to indicate a termination of epidermal patch operation when the desired phenotypic response has been achieved.

12. The method as recited in 11 further comprising the step of sending signals from the patch to a central control unit, wherein the signals include information pertinent to the operation of the sonic generator.

13. The method as recited in claim 12 further comprising the step of comparing the monitored information resulting from phenotypic differentiation with the desired phenotypic response to determine when the desired phenotypic response has been achieved.

14. The method as recited in claim 13 wherein the information resulting from phenotypic differentiation is epigenetic information regarding the expression level of the target tissue.

15. The method as recited in claim 14 further comprising the step of varying the frequency of the sonic wave in accordance with the scheduled program.

16. The method as recited in claim 11 wherein the titrating step is accomplished using a device selected from a group consisting of an Optical Coherence Tomography (OCT) device, an ultrasound device and instruments for performing a biopsy of the target tissue.

17. The method as recited in claim 11 wherein the predetermined sonic frequency is selected from a sonic spectrum including infrasonic, audible sonic, and ultrasonic frequencies, and further wherein the phenotypic response is selected from the group consisting of improved health and wellness, and meditative and brain wave/relaxation states.

18. The method as recited in claim 11 wherein the sonic wave has a frequency resonant with the natural frequency of the target tissue.

19. An epidermal patch for directing vibrational oscillating sonic waves toward a target tissue in the body of a person to influence a phenotypic differentiation of the target tissue at a cellular level which comprises:

a base member;

a means for holding the base member in a preselected location on the person;

a sonic generator mounted on the base member for generating a sonic wave in accordance with a scheduled program, wherein the sonic wave includes at least one predetermined frequency from the program to entrain cellular functions of the target tissue for a desired phenotypic response;

a unit for titrating the target tissue to monitor for changes in an expression level of the target tissue resulting from phenotypic differentiation, and to indicate a termination of epidermal patch operation when the desired phenotypic response has been achieved;

a transceiver mounted on the base member and connected with the sonic generator; and

a central control unit for receiving signals from the transceiver, wherein the signals include information pertinent to the operation of the sonic generator.

20. The patch as recited in claim 19 wherein the titration unit is connected to the central control unit to provide the central control unit with epigenetic information regarding the expression level of the target tissue pertinent to the phenotypic differentiation of the target tissue, and wherein the central control unit varies the frequency of the sonic wave in accordance with the scheduled program, and compares information from the titration unit with the desired phenotypic response to determine when the desired phenotypic response has been achieved.

Assignments (2)
CHANGE OF NAME Recorded Apr 25, 2023
From: STRATHSPEY CROWN, LLC
To: CROWN HOLDINGS, LLC
Reel/Frame 063439/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2015
From: GRANT, ROBERT EDWARD; MIRZAI, TODD; CASE, MATTHEW T.
To: STRATHSPEY CROWN HOLDINGS, LLC
Reel/Frame 036327/0902 →
Continuity (2)
Continuation In Part 14488101 · Sep 16, 2014
Related Publication 20160074277A1 · Mar 17, 2016